MedTrace Logo

Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases

NCT02922699 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2016-10-04

No results posted yet for this study

Summary

Comparison of efficacy of H.pylori eradication during first line therapy using standard or high doses of omeprazole administered twice daily in combination with amoxicillin and clarithromycin for 10 days.

Conditions

  • GERD

Interventions

DRUG

OMEZ 40

Omez 40 given to patients for 58days along with Amoxicilin and Clarithromycin

DRUG

OMEZ 80

Omez 80 patients for 58days along with Amoxicilin and Clarithromycin

Sponsors & Collaborators

  • Dr. Reddy's Laboratories Limited

    lead INDUSTRY

Principal Investigators

  • V.D Pasechnikov, MD · Stavropol State Medical University1

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-06-30
Completion
2013-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02922699 on ClinicalTrials.gov